Clinical Trial Update: Latino Semaglutide Study [Phase 3]

View source ↗

Summary

The Phase 3 Latino Semaglutide obesity trial has completed, providing an update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Latino Semaglutide (semaglutide)

Snippet

Sponsor: Loma Linda University | Conditions: Obesity, Obesity; Drug | Phase 3 | Status: COMPLETED